7CAL DWELL JE, CASTAGNOLI KP, CANFELL PC, et al. Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action[J]. Br J Anaesth, 1988, 6t(6): 693-697.
8MARSHALL RJ, MCGRATH JC, MILLER RD. et al. Comparison of cardiovascular actions of org-NC45 with those produced by other non-depolarising neuromuscular blocking agents in experimental animals[J]. Br J Anaesth 1980, 52(Suppl 1): 21-33.
9WIERDA JM, RICHARDSON JF, AGOSTON S. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl [J]. Anesth Analg, 1989, 68 (3): 208-213.
10ROBERTS SP, RAMSAY TM, HEALY TE, et al. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an ahernative to pipecuronium [J]. Anaesthesia 1993, 48(3): 196-199.